Bausch & Lomb Incorporated v. New Era Real Estate Solutions LLC
1:21-cv-00731
Overview
Parties
Defendant
New Era Real Estate Solutions LLC NPE (Patent Assertion Entity)
Represented By
0 Attorneys ListedPlaintiff
PF Consumer Healthcare 1 LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Bausch & Lomb Incorporated Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 20 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| π°π· South Korea | South Korea Counterpart | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| π¨π³ China | China Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6660297
Nutritional supplement to treat macular degeneration
|
Filed: 2001-03-23
Issued: 2003-12-09
|
Expired (Term Ended)
Expires: 2021-03-23
|
|
|
US8603522
Nutritional supplement to treat macular degeneration
|
Filed: 2005-01-13
Issued: 2013-12-10
|
Expired (Term Ended)
+383d PTA
Expires: 2026-01-31
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).